Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: U.S.
Take action: Health Gap starts campaign
Read what the Health Gap campaign is about: Five million people worldwide have access to HIV treatment, thanks in large part to the availability of cheap generic medication produced in India. India has a history of standing up to Big … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, Health Gap, HIV/Aids, India, U.S.
Leave a comment
Documents: Oxfam study on data exclusivity in the US-Jordan FTA
Oxfam briefing paper – All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines “The USA continues to impose TRIPS-plus rules on developing countries, thus preventing poor people from accessing inexpensive, generic medicines. … Continue reading
bilaterals.org: Put a hold on FTAs unfavourable to us
Source: bilaterals.org, 15.12.2010, by SM Mohamed Idris “The Malaysian government last week negotiated free trade agreements (FTAs) with the United States of America (via the Trans-Pacific Partnership Agreement or TPP) and the European Union (EU). [...] The US and EU … Continue reading
Posted in EU-Malaysia FTA, Trans-Pacific Partnership Agreement
Tagged EU, FTA, Intellectual property, Malaysia, New Zealand, U.S.
Leave a comment
KEI: US Industry IP demands on the TPP negotiations leaked
Knowledge Ecology International (KEI) has received a copy of U.S. industry demands on the Intellectual Property chapter of the Trans-Pacific Partnership Agreement (TPP) negotiations. A draft letter from US industry to USTR has been leaked [..]. The letter was prepared … Continue reading
Posted in Trans-Pacific Partnership Agreement
Tagged ACTA, Intellectual property, TPPA, TRIPS, U.S., WTO
Leave a comment
Public Citizen: Leaked New Zealand Paper Challenges Past U.S. FTA Models in Trans-Pacific Trade Negotiations
Washington, D.C., 04.12.2010 – Access to Medicines at Stake – A confidential Trans-Pacific Partnership Agreement (TPPA) negotiating paper authored by New Zealand suggests that the trade pact’s patent and copyright provisions be no more stringent than existing global standards. Warning … Continue reading
Malaysia: NGOs handed over memorandum to Government
Malaysia, 03.12.2010 – A group of NGOs representing the Anti-FTA Coalition gathered on Thursday, 3 Dec 2010 at the Malaysian Ministry of International Trade and Industry (MITI) to hand over a memorandum addressed to the Minister to register their concerns … Continue reading
Posted in EU-Malaysia FTA, Letters to officials, Trans-Pacific Partnership Agreement
Tagged EU, FTA, Malaysia, U.S.
Leave a comment
Malaysian PLWHA call for end to EU and US FTA negotiations
Malaysia, 01.12.2010 – On World AIDS Day the Positive Malaysian Treatment Access & Advocacy Group (MTAAG+), a group of people living with HIV/AIDS,[1] calls on the Malaysian Government to stop negotiating free trade agreements (FTAs) that could endanger access to … Continue reading
Posted in EU-Malaysia FTA, Trans-Pacific Partnership Agreement
Tagged EU, FTA, HIV/Aids, Intellectual property, Malaysia, PLWHA, U.S., World Trade Organization
Leave a comment
Press: Generic drugs bring down costs in poorest countries
Source: The Independent, 01.12.2010, by Nikhil Kumar Responding to criticism of the high cost of HIV drugs, pharma firms have spent the past decade stepping up efforts to improve access to treatments in poorer countries. Initiatives range from heavy discounts … Continue reading
Posted in HIV/Aids
Tagged Generic drug, HIV/Aids, India, Médecins Sans Frontières, U.S.
Leave a comment
Press: Big pharma and the business of HIV/AIDS
Source: The Independent, 01.12.2010, by Nikhil Kumar – Antiretrovirals have been a lucrative product for the world’s biggest drugs companies “The cost of treating HIV with antiretrovirals has plummeted during the past decade. Prices for the six most common initial … Continue reading
Posted in EU-India FTA, HIV/Aids
Tagged EU, FTA, Generic drugs, India, Médecins Sans Frontières, U.S.
Leave a comment
